Skip to main content

Obagi Nu-Derm System Normal-Dry Skin Transformation

Generic: Hydroquinone, Titanium Dioxide, and Zinc Oxide

Verified·Apr 23, 2026
Manufacturer
Obagi
NDC
62032-918
RxCUI
197795
ICD-10 indication
Z29.8

Affordability Check

How much will you actually pay for Obagi Nu-Derm System Normal-Dry Skin Transformation?

In 30 seconds, see every legitimate way to afford Obagi Nu-Derm System Normal-Dry Skin Transformation — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Obagi Nu-Derm System Normal-Dry Skin Transformation

What is this medication? The Obagi Nu-Derm System for normal to dry skin is a comprehensive, physician-dispensed skin care regimen designed to transform the appearance of aging and photodamaged skin. It is primarily used to address skin concerns such as hyperpigmentation, dark spots, fine lines, wrinkles, and uneven skin texture. By utilizing specific concentrations of active ingredients like hydroquinone, the system works to inhibit melanin production and accelerate skin cell turnover, leading to a more youthful and clearer complexion.

This specific formulation is tailored for individuals with normal to dry skin types, providing necessary hydration while the corrective components work on the skin's deeper layers. The multi-step process includes a cleanser, toner, brightening cream, exfoliant, and blender, which are often used in conjunction with a prescription retinoid. Over a period of several weeks, the system penetrates the skin to treat damage at the cellular level, helping to restore a healthy glow and improve the overall elasticity and health of the facial skin.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Obagi Nu-Derm System Normal-Dry Skin Transformation. Official source: DailyMed (NLM) · Label effective Nov 4, 2025

Indications and usage
Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Dosage and administration
Directions apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m.–2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses children under 6 months: Ask a doctor
Warnings
Warnings For external use only Do not use on damaged or broken skin Stop use and ask a doctor if rash occurs When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.